Quick Answer
Evolent Health, Inc. reported Operating Income of -$410.14 million for fiscal year 2025.
Evolent Health, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$410.14M | -913.1% |
| 2024 | -$40.48M | +43.1% |
| 2023 | -$71.21M | -2055.3% |
| 2022 | $3.64M | +108.6% |
| 2021 | -$42.41M | +83.9% |
| 2020 | -$262.85M | +14.9% |
| 2019 | -$308.88M | -550.6% |
| 2018 | -$47.48M | +34.8% |
| 2017 | -$72.84M | +69.3% |
| 2016 | -$237.42M | -452.5% |
| 2015 | -$42.97M | — |
| 2014 | $0.00 | +100.0% |
| 2013 | -$21.16M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $886.0K | +105.4% | +175.7% |
| June 30, 2025 | -$1.17M | -115.0% | +27.8% |
| March 31, 2025 | -$1.62M | +87.9% | +90.0% |
| September 30, 2024 | -$16.27M | +9.3% | -308.9% |
| June 30, 2024 | $7.79M | +136.1% | +158.1% |
| March 31, 2024 | -$13.41M | -29.5% | +25.2% |
| September 30, 2023 | -$17.94M | -238.5% | +16.8% |
| June 30, 2023 | -$21.57M | -365.5% | -108.3% |
- Evolent Health, Inc. showed a decrease of -913.1% in Operating Income compared to the prior fiscal year.
- Over the 2013–2025 period, Evolent Health, Inc.’s operating income has declined by 1838.7% (from -$21.16 million to -$410.14 million).
- The most recent figure is from Evolent Health, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: